TALLAHASSEE, Fla., March 29, 2011 /PRNewswire/ -- Public/Private Sector Strategies for America's Health Care Future (PS2) has delivered to Florida Senate President Mike Haridopolos, R-Melbourne, its report detailing how the state can reduce its spending on pharmaceuticals. The report makes recommendations in 21 areas that conservatively would save Florida taxpayers up to $170 million a year.
"Our charge was to identify steps the state could take that would result in maximum savings and at the same time mitigate the harm to those served by the various state programs," Jeffrey Lewis, president of PS2, said. "The PS2 blueprint provides the Legislature with a roadmap to achieve effective and important legislative changes to smart prescription drug purchasing and management. It demonstrates real solutions for real problems."
PS2's report, The Florida Rx Blueprint: Achieving Greater Savings for Florida's Taxpayers, will assist public policymakers as they seek to reduce government spending. The report provides an explanation of the pharmaceutical problems the state faces and solutions to those problems. As the analysis notes, some of the issues involved are complicated.
Some of the report's recommendations are:
- Change the way Medicaid operates its prescription drug program by creating a single list of drugs from which all doctors must prescribe to control costs and eliminate abuse more effectively. The savings would be $50 million.
- Change the way specialty medications (high-cost drugs that require special handling and administration, temperature-controlled shipping and careful adherence to treatment protocols) are managed.
- Create a rational way to pay pharmacists for dispensing medications. Rather than legislate a fee, allow the private market to work just as in the private sector.
- Expand a pilot program that uses county health departments to treat Department of Corrections' inmates with HIV/AIDS and other sexually transmitted diseases. By expanding the program, the department could leverage better its use of a special federal price discount program and reduce its prescription drug costs by $7.2 million.
- Choose a single vendor through a competitive bidding process instead of having the state continue to use five different pharmacy benefit managers for various pharmacy health programs either directly or through managed care.
- Promote more effectively the use in state programs of generic drugs, which are significantly less expensive than brand-name drugs.
Currently, the state of Florida spends more than $1.5 billion on pharmaceuticals. These expenses are incurred by at least seven state agencies with a multitude of programs. A constant theme of the report is a lack of coordination among state departments, a lack of transparency and lack of value-based contracting.
The Florida Senate commissioned the Rx Blueprint report. A full copy is available at: www.ps2healthcare.org.
Related medicine technology :1
|SOURCE Public/Private Sector Strategies for America's Health Care Future|
Copyright©2010 PR Newswire.
All rights reserved
. Senate Told Brain Technology Can Impact Public Policy2
. Senate Introduces Bill to Boost Participation in Clinical Trials for Rare Diseases3
. AST on Capitol Hill to Promote Transplant Drug Extension Provision With Senate as Part of Health Care Reform4
. PhRMA Statement on Senate Finance Committee Vote5
. Senate Rejects Bulk Imports of Medicine from Canada, but Personal Importation Remains a Popular Option for U.S. Citizens6
. Physician Groups Oppose Current Senate Health Care Reform Bill7
. RetireSafe Urges Senate to Defeat Senate Amendment 2793 -- Says Senator Dorgans Drug Importation Plan Puts Seniors at Risk8
. GlaxoSmithKline Responds to US Senate Committee on Finance Report on Avandia9
. World TB Day Senate Briefing10
. NACDS, NCPA Back Senate Medication Therapy Management Bill11
. Amicus CEO Represents BIO on Rare Diseases at U.S. Senate Committee on Health, Education, Labor and Pensions Bipartisan Hearing